LSVT LOUD References

Data-based articles evaluating the efficacy of the LSVT LOUD in Parkinson’s and atypical PD

**Sale P, Castiglioni D, De Pandis MF, Torti M, Dall’armi V, Radicati FG, Stocchi F. (2015). The Lee Silverman Voice Treatment (LSVT®) speech therapy in progressive supranuclear palsy. European Journal of Physical and Rehabilitation Medicine, 51(5), 569-74. PMID: 26138088

**Sauvageau VM, Roy JP, Langlois M, Macoir J. Impact of the LSVT on vowel articulation and coarticulation in Parkinson’s disease. (2015). Clinical Linguistics & Phonetics, 29(6), 424-40. PMID: 25688915

Dumer, A. I., Oster, H., McCabe, D., Rabin, L. A., Spielman, J. L., Ramig, L. O., & Borod, J. C. (2014). Effects of the Lee Silverman Voice Treatment on Facial Expressivity in Parkinson’s Disease. Journal of the International Neuropsychological Society. 20(3), 302-12.

**Cannito MP, Suiter DM, Beverly D, Chorna L, Wolf T, Pfeiffer RM. (2012). Sentence intelligibility before and after voice treatment in speakers with idiopathic Parkinson’s disease. Journal of Voice, 26(2), 214-9.

**Whitehill, T. L., Kwan, L., Lee, F. P.-H., & Chow, M. M.-N. (2011). Effect of LSVT on Lexical Tone in Speakers with Parkinson’s Disease. Parkinson’s Disease, 2011, 897494. http://doi.org/10.4061/2011/897494

Spielman, J., Mahler, L., Halpern, A., Gilley, P., Klepitskaya, O., & Ramig. L. (2011). Intensive Voice Treatment (LSVT® LOUD) for Parkinson’s disease following Deep Brain Stimulation of the Subthalamic Nucleus. Journal of Communication Disorders, 44, 688-700. PMCID: PMC3210871. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210871/

Narayana, S., Fox, P. T., Zhang, W., Franklin, C., Robin, D. A., Vogel, D., & Ramig, L. O. (2010). Neural Correlates of Efficacy of Voice Therapy in Parkinson’s Disease Identified by Performance–Correlation Analysis. Human Brain Mapping, 31(2), 222–236.

Sapir, S., Ramig, L., Spielman, J., & Fox, C. (2010). Formant Centralization Ratio (FCR): A proposal for a new acoustic measure of dysarthric speech. Journal of Speech, Language and Hearing Research, 53, 114-125. PMCID: PMC2821466.

Sapir, S., Spielman, J., Ramig, L., Story, B., & Fox, C. (2007). Effects of intensive voice treatment (LSVT®) on vowel articulation in dysarthric individuals with idiopathic Parkinson’s disease: Acoustic and perceptual findings. Journal of Speech Language and Hearing Research, 50, 899-912.

Spielman, J., Ramig, L., Mahler, L., Halpern, A., & Petska, J. (2007). Effects of LSVT Extended (LSVT-X) on Voice and Speech in Parkinson Disease. American Journal of Speech, Language Pathology, 16, 95-107.

**Whitehill TL, Wong LL. (2007). Effect of intensive voice treatment on tone-language speakers with Parkinson’s disease. Clinical Linguistics and Phonetics, 21(11-12), 919-25.

Huber, J., Stathopoulos, E., Ramig, L., & Lancaster, S. (2003). Respiratory function and variability in individuals with Parkinson disease: pre and post Lee Silverman Voice Treatment (LSVT®). Journal of Medical Speech-Language Pathology, 11(4), 185-201.

Liotti, M., Vogel, D., Ramig, L., New, P., Cook, C., Ingham, R.J., Ingham, J.C., & Fox, P. (2003). Hypophonia in Parkinson’s disease: neural correlates of voice treatment revealed by PET. Neurology, 60, 432-440.

Spielman, J., Borod, J., & Ramig. L. (2003). Effects of intensive voice treatment (LSVT®) on facial expressiveness in Parkinson’s disease: Preliminary Data. Cognitive and Behavioral Neurology. 16(3), 177-188.

El Sharkawi, A., Ramig, L., Logemann, J., Pauloski, B., Rademaker, A., Smith, C., … Werner, C. (2002). Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT®): a pilot study. Journal of Neurology, Neurosurgery, and Psychiatry, 72(1), 31–36. http://doi.org/10.1136/jnnp.72.1.31

Sapir, S., Ramig, L., Hoyt, P, O’Brien, C., & Hoehn, M. (2002). Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson’s disease: a comparison with an alternative speech treatment. Folia Phoniatrica, 54, 296-303.

Baumgartner, C., Sapir, S., & Ramig, L. (2001). Voice quality changes following phonatory- respiratory effort Treatment (LSVT®) versus respiratory effort treatment for individuals with Parkinson disease. Journal of Voice, 15(1), 105-114.

Ramig, L., Sapir, S., Countryman, S., Pawlas, A., O’Brien, C., Hoehn, M., & Thompson, L. (2001). Intensive voice treatment (LSVT®) for patients with Parkinson’s disease: a 2 year follow up. Journal of Neurology, Neurosurgery, and Psychiatry, 71(4), 493–498. http://doi.org/10.1136/jnnp.71.4.493

Ramig, L., Sapir, S., Fox, C., & Countryman, S. (2001). Changes in vocal intensity following intensive voice treatment (LSVT®) in individuals with Parkinson disease: A comparison with untreated patients and normal age-matched controls. Movement Disorders, 16, 79-83.

Sapir, S., Pawlas, A., Ramig, L., Seeley, E., Fox, C., & Corboy, J. (2001). Effects of intensive phonatory-respiratory treatment (LSVT®) on voice in two individuals with multiple sclerosis. Journal of Speech Language Pathology, 9(2), 35-45.

Countryman, S., Hicks, J., Ramig, L., & Smith, M. (1997). Supraglottal hyperadduction in an individual with Parkinson disease: A clinical treatment note. American Journal of Speech-Language Pathology, 6(4), 74-84.

Ramig, L., Countryman, S., O’Brien, C., Hoehn, M., & Thompson, L. (1996). Intensive speech treatment for patients with Parkinson disease: Short and long-term comparison of two techniques. Neurology, 47, 1496-1504.

Ramig, L., & Dromey, C. (1996). Aerodynamic mechanisms underlying treatment related changes in SPL in patients with Parkinson disease. Journal of Speech and Hearing Research, 39, 798-807.

Dromey, C., Ramig, L., & Johnson, A.B. (1995). Phonatory and articulatory changes associated with increased vocal intensity in Parkinson disease: A case study. Journal of Speech and Hearing Research, 38, 751-764.

Ramig, L., Countryman, S., Thompson, L., & Horii, Y. (1995). A comparison of two forms of intensive speech treatment for Parkinson disease. Journal of Speech and Hearing Research, 38, 1232-1251.

Smith, M.E., Ramig, L., Dromey, C., Perez, K.S., & Samandari, R. (1995). Intensive voice treatment in Parkinson’s disease: Laryngostroboscopic findings. Journal of Voice, 9, 453-459.

Countryman, S., Ramig, L., & Pawlas, A. (1994). Speech and voice deficits in Parkinsonian Plus syndromes: Can they be treated? Journal of Medical Speech-Language Pathology, 2(3), 211-225.

Ramig, L., Bonitati, C.M., Lemke, J.H., & Horii, Y. (1994). Voice treatment for patients with Parkinson disease: Development of an approach and preliminary efficacy data. Journal of Medical Speech-Language Pathology, 2(3), 191-209.

Countryman, S., & Ramig, L. (1993). Effects of intensive voice therapy on voice deficits associated with bilateral thalamotomy in Parkinson’s disease: A case study. Journal of Medical Speech-Language Pathology, 1, 233-250.